Trump's 100 Percent Pharma Tariff to Have Twofold Impact on Indian Drugmakers
The proposed tariffs target only branded and patented medicines, leaving India’s generic exports largely unaffected. While companies making branded drugs for the US may face challenges, domestic generic producers could benefit from increased demand for affordable alternatives.
US President Donald Trump | 29/09/2025 | By Dineshwori | 306
Trump Directs HHS to Fill Strategic API Reserve to Bolster Pharma Supply Chain
US President Donald Trump has signed an executive order to strengthen the American pharmaceutical supply chain resilience by filling the Strategic Active Pharmaceutical Ingredients Reserve (SAPIR).
US President Donald Trump | 14/08/2025 | By Dineshwori | 194
Celltrion Announces Three-Stage Strategy to Counter Trump's Pharma Tariff Plan
Celltrion has announced its response strategy to US President Donald Trump’s plan to impose tariffs on pharmaceuticals.
US President Donald Trump | 10/07/2025 | By Dineshwori | 408
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy